Issues related to healthcare funding and cost-savings. Issues related to access to pharmaceuticals, international finance for health services and intellectual property protection. HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act. Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; H.R. 6 - 21st Century Cures Act. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016;  S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.The FOCUS program. Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV testing, screening and linkage to care programs; H.R. 6 - 21st Century Cures Act. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; Implementation of Public Law No: 111-148; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B. International trade and protection of intellectual property Incarcerated population relating to Hepatitis C and health care. Coverage of pharmaceuticals, cost-sharing and other access issues; H.R. 6 - 21st Century Cures Act; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid, and Affordable Care Act implementation; FDA issues and 340B. S. 3056 - CREATES Act of 2016. Appropriations; Education related to Hepatitis C treatment guidelines (veterans) and funding issues (FY17 Appropriations bill). Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146. Health care for judiciary involved veterans.
BUD - Budget/Appropriations FOR - Foreign Relations CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid TRD - Trade (domestic/foreign) LAW - Law Enforcement/Crime/Criminal Justice PHA - Pharmacy VET - Veterans
24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 42 - Veterans Affairs, Dept of (VA) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 42 - Veterans Affairs, Dept of (VA) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 42 - Veterans Affairs, Dept of (VA) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 42 - Veterans Affairs, Dept of (VA) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 42 - Veterans Affairs, Dept of (VA) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 42 - Veterans Affairs, Dept of (VA) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 42 - Veterans Affairs, Dept of (VA) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 42 - Veterans Affairs, Dept of (VA) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 42 - Veterans Affairs, Dept of (VA)
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404, US
JOSEPH GROGAN DAVID PULLIAM JOSEPH GROGAN JOSEPH GROGAN DAVID PULLIAM JOSEPH GROGAN DAVID PULLIAM JOSEPH GROGAN DAVID PULLIAM JOSEPH GROGAN DAVID PULLIAM JOSEPH GROGAN DAVID PULLIAM JOSEPH GROGAN DAVID PULLIAM JOSEPH GROGAN DAVID PULLIAM